Gastroenterology
Manal Abdelmalek, MD
Professor of Medicine; Director, MASLD Clinical Research Program, Division of Gastroenterology & Hepatology
Dr. Manal F. Abdelmalek, MD, MPH is a leading hepatologist specializing in metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). As a tenured Professor of Medicine in Gastroenterology and Hepatology, she directs the MASLD Clinical Research Program and has been a key opinion leader in MASH therapeutics for
30+
Years in Practice
Credentials
Board Certifications
- Gastroenterology and Hepatology (ABIM)
- Internal Medicine (ABIM)
Education & Training
- University of Missouri–Kansas City School of Medicine — M.D. (1992)
- Mayo Clinic, Rochester, MN — Residency, Internal Medicine (1995)
- Mayo Clinic, Rochester, MN — Fellowship, Gastroenterology and Hepatology
- University of Florida, Gainesville, Florida — M.P.H. (emphasis in epidemiology, public health, and clinical investigation)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Duke University Hospital
- Mayo Clinic
Languages
English, Arabic
Experience
30+ years in practice